Efficacy of contrast-enhanced endoscopic ultrasonography for diagnosing abdominal or mediastinal enlarged lymph nodes: muticenter pilot study

Efficacy of contrast-enhanced endoscopic ultrasonography for diagnosing abdominal or mediastinal enlarged lymph nodes: muticenter pilot study - CE-EUS for enlarged LN

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024298

Enrollment

100

Registered

2016-10-04

Start date

2016-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

enlarged mediastinal or abdominal LN

Interventions

Contrast-enhanced endoscopic ultrasonography

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patient with enlarged lymph nodes around upper gastrointestinal tract by imaging study 2)Patient who will undergo endoscopic ultrasound-guided fine-needle aspiration for enlarged lymph nodes 3)ECOG performance status = 0-2 4)Written informed consent

Exclusion criteria

Exclusion criteria: 1) Inappropriate to perform endoscopic ultrasonography 2) Blood coagulation disorder or decreased platelet counts. Taking anticoagulant or anti-platelet drugs 3) Allergy to eggs 4) possible pregnancy 5) Failure of other organs (ASA:Grade3,4)

Design outcomes

Primary

Measure	Time frame
Diagnostic ability by using qualitative evaluation of contrast-enhanced endoscopic ultrasonography	—

Secondary

Measure	Time frame
To assess the usefulness of quantitative evaluation by using TIC analysis	—

Countries

Japan

Contacts

Public ContactTakuji Iwashita

Gifu University Hospital First Department of Internal Medicine

takuji-guh@umin.ac.jp058-230-6308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026